Stay updated on Talquetamab Dose Escalation in Myeloma Clinical Trial
Sign up to get notified when there's something new on the Talquetamab Dose Escalation in Myeloma Clinical Trial page.

Latest updates to the Talquetamab Dose Escalation in Myeloma Clinical Trial page
- CheckyesterdayChange DetectedThe page's revision label updated from v3.5.4 to v3.5.5, signaling a new build release. This update is a minor internal version change and does not modify study content or user-facing features.SummaryDifference0.0%

- Check8 days agoNo Change Detected
- Check15 days agoNo Change Detected
- Check22 days agoChange DetectedA new revision entry (v3.5.4) dated 2026-05-08 with an added 'Study Status' section appears in the history, replacing the prior revision entry (v3.5.3) dated 2026-04-13.SummaryDifference0.2%

- Check36 days agoChange DetectedThe study history now shows a new revision tag (v3.5.3), indicating a minor update to the page version of the record.SummaryDifference0.0%

- Check51 days agoChange DetectedA new history entry was added for Study Status with Revision v3.5.2 (dated 2026-04-13), and the prior Revision v3.5.0 was removed (dated 2026-03-12).SummaryDifference0.2%

- Check79 days agoChange DetectedA new version entry dated 2026-03-12 for Study Status (revision v3.5.0) was added to the history, and the prior 2026-02-13 revision (v3.4.3) was removed.SummaryDifference0.2%

- Check86 days agoChange DetectedRevision: v3.4.3 was added and Revision: v3.4.2 was removed in the page history. This is a system version update rather than a change to trial data.SummaryDifference0.0%

Stay in the know with updates to Talquetamab Dose Escalation in Myeloma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Talquetamab Dose Escalation in Myeloma Clinical Trial page.